Search research articles
Contact Us
Filters
Showing results (31-40 of 148) with videos related to
Page
of 15
Sort By:
Advances in Internal Medicine
|
January 1, 1984
Renal osteodystrophy
J W Coburn, D A Henry
The Medical Journal of Australia
|
November 18, 1991
The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trials
J S Silberberg, D A Henry
BMJ (Clinical Research Ed.)
|
April 29, 1989
Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage
D A Henry, D L O'Connell
The Journal of Antimicrobial Chemotherapy
|
December 1, 1988
Comparison of bactericidal activity of selected beta-lactam antimicrobials against Pseudomonas aeruginosa
J A Smith, D A Henry
British Medical Journal
|
March 12, 1977
Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"?
D H Lawson, D A Henry
Bailliere'S Clinical Gastroenterology
|
June 1, 1994
Drugs as a cause of gastrointestinal disease
D A Henry, G Ostapowicz, J Robertson
The Medical Journal of Australia
|
April 17, 1989
The use of non-prescription salbutamol inhalers by asthmatic patients in the Hunter Valley, New South Wales. Newcastle Retail Pharmacy Research Group
D A Henry, D Sutherland, L Francis
The Medical Journal of Australia
|
March 20, 1989
Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning
A H Dawson, D A Henry, J McEwen
Antimicrobial Agents and Chemotherapy
|
November 1, 1990
Disk elution method for MICs and MBCs
E Wilson, D A Henry, J A Smith
Digestive Diseases and Sciences
|
September 1, 1985
[14C]Aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis
D A Henry, G Kitchingman, M J Langman
Page
of 15
Search research articles
Search
Showing results (31-40 of 148) with videos related to
Sort By:
Page
of 15
Advances in Internal Medicine
|
January 1, 1984
Renal osteodystrophy
J W Coburn, D A Henry
The Medical Journal of Australia
|
November 18, 1991
The benefits of reducing cholesterol levels: the need to distinguish primary from secondary prevention. 1. A meta-analysis of cholesterol-lowering trials
J S Silberberg, D A Henry
BMJ (Clinical Research Ed.)
|
April 29, 1989
Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage
D A Henry, D L O'Connell
The Journal of Antimicrobial Chemotherapy
|
December 1, 1988
Comparison of bactericidal activity of selected beta-lactam antimicrobials against Pseudomonas aeruginosa
J A Smith, D A Henry
British Medical Journal
|
March 12, 1977
Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"?
D H Lawson, D A Henry
Bailliere'S Clinical Gastroenterology
|
June 1, 1994
Drugs as a cause of gastrointestinal disease
D A Henry, G Ostapowicz, J Robertson
The Medical Journal of Australia
|
April 17, 1989
The use of non-prescription salbutamol inhalers by asthmatic patients in the Hunter Valley, New South Wales. Newcastle Retail Pharmacy Research Group
D A Henry, D Sutherland, L Francis
The Medical Journal of Australia
|
March 20, 1989
Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning
A H Dawson, D A Henry, J McEwen
Antimicrobial Agents and Chemotherapy
|
November 1, 1990
Disk elution method for MICs and MBCs
E Wilson, D A Henry, J A Smith
Digestive Diseases and Sciences
|
September 1, 1985
[14C]Aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis
D A Henry, G Kitchingman, M J Langman
Page
of 15